Frontage Laboratories | 01-Dec-2019
| Technical / White Paper
Biologics are complex large molecules derived from living organisms or manufactured from cells, and they have inherent structural heterogeneity. Indeed,...
Frontage Laboratories | 01-Oct-2019
| Technical / White Paper
Over the years, the pharmaceutical industry has made steady progress in improving the safety of drugs in development. Consequently, in 2015, only 14 percent...
Frontage Laboratories | 01-Oct-2019
| Technical / White Paper
Frontage is the first and only laboratory to validate Quanterix’ Simoa HD1 Analyzer for performing immunoassays. Most of the advanced instruments used...
Frontage Laboratories | 21-Aug-2019
| Technical / White Paper
Immunogenicity is the leading reason that biologics fail in clinical trials, and thus it has become imperative for drug development programs to include...
BBK Worldwide | 24-Jul-2019
| Technical / White Paper
Despite growing evidence, the myth that physicians won’t refer patients to clinical trials persists, perpetuated by the belief that they fear losing their...
In May 2018 Outsourcing-Pharma.com, in association with InnovoCommerce, conducted its second annual ‘state of the industry’ survey on its user base of...
You have the power to make a difference. To make new therapeutics that improve quality of life and inspire a healthier world. To do this, you need a manufacturing...
Butterworth | 26-May-2016
| Technical / White Paper
The International Conference of Harmonisation (ICH) guidance document on elemental impurities, Q3D, reached step 4 in December 2014, meaning the final...
Butterworth | 24-Sep-2015
| Technical / White Paper
The classic Modified Atmosphere Packaging (MAP) application, in the pharmaceutical industry, uses medical grade nitrogen to purge atmospheric oxygen and...
Butterworth | 12-May-2015
| Technical / White Paper
Samplestorage, handling anddelivery are as important in the determination of residual solvents as the analysis itself. This paper provides practical advice...
